Study details
Enrolling now
Ultra-Low Contrast Angiography in AKI
Tulane University
NCT IDNCT05906758ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
32
Study length
about 1.3 years
Ages
18–100
Locations
2 sites in LA
What this study is about
This trial is testing whether ultra-low contrast angiography is safe for people with kidney problems. It's a procedure to look at the heart arteries, and it will be done on adults who have developed kidney issues during hospitalization. The goal is to see if ultra-low contrast angiography can be used safely in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Angiography
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
angiography
Body systems
Renal